Progressive Care, Inc.

    Progressive Care, Inc.

    OOTC:RXMD
    - -
    USD
    - -
    - -
    Progressive Care, Inc.
    OTC:RXMD
    (OTC Markets)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2008
    2009
    2010
    2010
    2011
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    TTM
    USD
    21.02
    9.1
    - -
    38.35
    46.55
    70.45
    71.92
    17.53
    10.65
    11.61
    9.87
    15.14
    16.85
    14.92
    13.94
    - -
    8.83
    Revenue per Share
    -13.14
    -9.61
    -3
    12.16
    -1.44
    -4.42
    -6.44
    -1.57
    0.12
    0.03
    -0.78
    -1.16
    -0.63
    0.08
    -2.21
    - -
    -3.91
    Basic EPS, GAAP
    -8.29
    -7.59
    -1.71
    8.38
    -1.41
    -3.33
    -0.52
    -0.39
    0.16
    -0.14
    -0.19
    -0.3
    0.21
    -0.34
    0.16
    - -
    0.15
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    -133.97
    -114.75
    -66.12
    10.68
    7.83
    -8.97
    -14.02
    -4.35
    -1.85
    -1.81
    -2.27
    -3.37
    -3.76
    -3.26
    -5.12
    - -
    -7.07
    Book Value per Share
    -16.83
    -7.56
    -5.58
    -18.56
    -10.21
    -7.82
    -12.41
    -0.09
    0.16
    0.25
    -0.04
    -1.96
    -1.47
    -0.44
    2.1
    - -
    2.09
    Tangible Book Value per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    2
    2
    2
    2
    2
    3
    3
    - -
    6
    Basic Weighted Avg Shares
    - -
    - -
    - -
    6
    8
    9
    11
    14
    18
    20
    21
    33
    39
    39
    41
    - -
    55
    Sales/Revenue/Turnover
    -57.31
    -95.58
    - -
    28.46
    -1.95
    -4.18
    -3.4
    -3.57
    1.88
    1.09
    -7.27
    -2.44
    -2.61
    -2.67
    -1.23
    - -
    -0.97
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    1
    - -
    - -
    3
    Depreciation Expense
    - -
    - -
    - -
    2
    - -
    -1
    -1
    -1
    - -
    - -
    -2
    -3
    -1
    - -
    -6
    - -
    -24
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    0.85
    1.13
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    -62.51
    -105.54
    - -
    31.72
    -3.09
    -6.27
    -8.96
    -8.94
    1.14
    0.24
    -7.9
    -7.68
    -3.72
    0.56
    -14.54
    - -
    -44.27
    Profit Margin (%)
    - -
    - -
    - -
    - -
    1
    -1
    -2
    - -
    - -
    - -
    -1
    -4
    -2
    - -
    6
    9
    11
    Working Capital
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    2
    2
    4
    4
    3
    1
    1
    LT Debt
    - -
    - -
    - -
    - -
    1
    -1
    -2
    - -
    - -
    - -
    - -
    -2
    -2
    - -
    8
    27
    17
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    113.41
    32.03
    - -
    - -
    - -
    -28.89
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    -8.91
    -5.41
    - -
    - -
    - -
    -38.62
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    -16.82
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    USD

    •

    in mil. unless spec.
    Dec'23
    Mar'24
    Jun'24
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    1
    1
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    - -
    6
    6
    Market Capitalization
    15
    13
    10

    Working Capital

    USD

    •

    in mil. unless spec.
    Dec'23
    Mar'24
    Jun'24
    Total Current Assets
    - -
    23
    21
    Cash, Cash Equivalents & STI
    - -
    6
    9
    Accounts Receivable, Net
    - -
    12
    9
    Inventories
    - -
    3
    2
    Total Current Liabilities
    - -
    14
    11
    Payables & Accruals
    - -
    14
    10
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    30.12%
    158.79%
    248.7%
    Free Cash Flow
    - -
    - -
    - -
    Net Income, GAAP
    - -
    - -
    - -
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    10
    10
    10
    10
    41
    2023
    11
    12
    12
    14
    - -
    2024
    15
    13
    - -
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    -0.5
    -0.32
    -3.29
    - -
    -2.21
    2023
    -0.04
    -1.05
    -0.22
    - -
    - -
    2024
    -0.06
    -1.49
    - -
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business

    Company News

    • ATKINS NAMED A WINNER IN PROGRESSIVE GROCER'S 2025 EDITORS' PICKS AWARDS

    • Progressive Care Inc. Announces Results of Special Meeting of Stockholders

    • NextPlat Reports 474% Increase in Consolidated Q2 Revenues to $17 Million and Record 34.2% Quarterly Margins; $70 Million in 2024 Annual Revenues Expected

    • Progressive Care Inc. Announces Second Quarter 2024 Revenues of $13.5 Million, an Increase of 17% as Gross Margin Expands to 35%

    • Global Telesat Begins Sales of SpaceX's Starlink as Authorized Reseller Through Joint Venture Agreement with Pivotel Solutions Inc. (dba Pulsar)

    • Q2 2024 Earnings Estimate for The Progressive Co. Issued By William Blair (NYSE:PGR)

    • Q2 2024 Earnings Estimate for The Progressive Co. (NYSE:PGR) Issued By Roth Capital

    • Progressive Care Inc. Announces Record First Quarter 2024 Revenues of $14.6 Million, an Increase of 28% Over First Quarter 2023 Results

    • NEXTPLAT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of NextPlat Corp - NXPL

    • NEXTPLAT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of NextPlat Corp - NXPL

    • RXMD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Progressive Care Inc. Is Fair to Shareholders

    • NextPlat Announces Proposed Business Combination with Progressive Care Inc.

    • NextPlat Reports Consolidated Year-End 2023 Results with Increased Revenues of $37.8 Million, Record Annual Margins of 30% and $26.3 Million in Cash

    • NextPlat Expands North American Technology E-Commerce Business with Acquisition of Outfitter Satellite Inc.

    • Progressive Care's PharmcoRx Pharmacies Expands Medicare Advantage Over-the-Counter Benefits Acceptance Program Through New Agreement with ProHealth Connect

    • PharmcoRx Pharmacy Launches Mark Cuban Cost Plus Drug Program Expanding Its In-Pharmacy Offerings

    • Progressive Care's PharmcoRx Enters into Agreement with NationsBenefits to Offer Enhanced OTC Benefits to Health Plan Members

    • Progressive Care Inc. Announces Record Second Quarter 2023 Results with Revenues of $11.6 Million and Gross Margins of 31%

    • Progressive Care Announces Shareholder Conference Call and Business Update on November 14, 2022

    • Progressive Care, Inc. (RXMD) CEO Alan Jay Weisberg on Q2 2022 Results - Earnings Call Transcript